SCHEMBL3852574

SCHEMBL3852574

O=S(=O)(c1ccc(OC2CCN(c3ccnc4ccc(-c5cn(C(c6ccccc6)(c6ccccc6)c6ccccc6)nc5C(F)(F)F)cc34)CC2)cc1)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 3/20 0.41
HTR1A P08908 2/20 0.36
HTR1D P28221 2/20 0.36
HTR1B P28222 2/20 0.36
HTR6 P50406 2/20 0.36
HTR2A P28223 1/20 0.36
PIK3CA P42336 4/20 0.35
CYP3A4 P08684 1/20 0.34
HPGD P15428 1/20 0.34
PDGFRB P09619 1/20 0.32
TP53 P04637 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
RECQL P46063 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
CHRM2 P08172 1/20 0.32
FFAR1 O14842 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3852758 0.93 CHRM4 (0.42) CHRM4HTR1AHTR1DHTR1BHTR6
SCHEMBL3848219 0.88 CHRM4 (0.40) CHRM4HTR1AHTR1DHTR1BHTR6
SCHEMBL3853501 0.87 CHRM4 (0.44) CHRM4HTR1AHTR1DHTR1BHTR6
SCHEMBL3855583 0.85 GPR119 (0.41) CHRM4HTR1AHTR1DHTR1BHTR6
SCHEMBL3855874 0.84 CHRM4 (0.39) CHRM4HTR1AHTR1DHTR1BHTR6
SCHEMBL3848728 0.84 CHRM4 (0.39) CHRM4HTR1AHTR1DHTR1BHTR6
SCHEMBL3849596 0.83 CHRM4 (0.44) CHRM4HTR1AHTR1DHTR1BHTR6
SCHEMBL3847665 0.83 CHRM4 (0.41) CHRM4PIK3CACYP3A4HPGDPDGFRB
SCHEMBL3848141 0.83 CYP3A4 (0.50) CYP3A4HPGDPDGFRBMTOR
SCHEMBL4715518 0.82 CHRM4 (0.42) CHRM4PIK3CAPIK3CDPIK3CBMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed